Scheffer IE, Harkin LA, Grinton BE, et al. Temporal lobe epilepsy and GEFS + phenotypes associated with SCN1B mutations. Brain J Neurol. 2007;130:100–9.
Howell KB, Eggers S, Dalziel K, et al. A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy. Epilepsia. 2018;59:1177–87.
PubMed PubMed Central Google Scholar
Willimsky EK, Munzig A, Mayer K, et al. Next generation sequencing in pediatric epilepsy using customized panels: size matters. Neuropediatrics. 2021;52:92–7.
Murthy MC, Banerjee B, Shetty M, Mariappan M, Sekhsaria A. A retrospective study of the yield of next-generation sequencing in the diagnosis of developmental and epileptic encephalopathies and epileptic encephalopathies in 0–12 years aged children at a single tertiary care hospital in South India. Epileptic Disord. 2024;26:609–25.
Nagarajan B, Gowda VK, Yoganathan S, et al. Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India. Epilepsia Open. 2023;8:1383–404.
PubMed PubMed Central Google Scholar
Zuberi SM, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63:1349–97.
Barcia G, Fleming MR, Deligniere A, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet. 2012;44:1255–9.
CAS PubMed PubMed Central Google Scholar
Burgess R, Wang S, McTague A, et al. The genetic landscape of epilepsy of infancy with migrating focal seizures. Ann Neurol. 2019;86:821–31.
CAS PubMed PubMed Central Google Scholar
Dravet C. Severe myoclonic epilepsy in infants and its related syndromes. Epilepsia. 2000;41:7.
Cetica V, Chiari S, Mei D, et al. Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations. Neurology. 2017;88:1037–44.
CAS PubMed PubMed Central Google Scholar
Steel D, Symonds JD, Zuberi SM, Brunklaus A. Dravet syndrome and its mimics: beyond SCN1A. Epilepsia. 2017;58:1807–16.
Sait H, Srivastava S, Kumar S, et al. Inborn errors of ketogenesis: novel variants, clinical presentation, and follow-up in a series of four patients. J Pediatr Genet. 2024;13:22–8.
Krygier M, Pietruszka M, Zawadzka M, et al. Next-generation sequencing testing in children with epilepsy reveals novel clinical, diagnostic and therapeutic implications. Front Genet. 2023;14:1300952.
Calhoun JD, Carvill GL. Epilepsy genetics: what once was rare, is now common. Epilepsy Curr. 2020;20:221–3.
PubMed PubMed Central Google Scholar
Mercimek-Mahmutoglu S, Patel J, Cordeiro D, et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. Epilepsia. 2015;56:707–16.
Vetri L, Calì F, Saccone S, et al. Whole exome sequencing as a first-line molecular genetic test in developmental and epileptic encephalopathies. Int J Mol Sci. 2024;25:1146.
CAS PubMed PubMed Central Google Scholar
Myers CT, Mefford HC. Advancing epilepsy genetics in the genomic era. Genome Med. 2015;7:91.
PubMed PubMed Central Google Scholar
Michaud JL, Lachance M, Hamdan FF, et al. The genetic landscape of infantile spasms. Hum Mol Genet. 2014;23:4846–58.
Allen AS, Berkovic SF, Cossette P, et al. Epi4K Consortium; Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature. 2013;501:217–21.
Reinson K, Õiglane-Shlik E, Talvik I, et al. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy. Am J Med Genet A. 2016;170:2173–6.
Fry AE, Fawcett KA, Zelnik N, et al. De novo mutations in GRIN1 cause extensive bilateral polymicrogyria. Brain J Neurol. 2018;141:698–712.
Lemke JR, Geider K, Helbig KL, et al. Delineating the GRIN1 phenotypic spectrum: a distinct genetic NMDA receptor encephalopathy. Neurology. 2016;86:2171–8.
CAS PubMed PubMed Central Google Scholar
Ramadan W, Patel N, Anazi S, et al. Confirming the recessive inheritance of SCN1B mutations in developmental epileptic encephalopathy. Clin Genet. 2017;92:327–31.
Bailey CS, Moldenhauer HJ, Park SM, Keros S, Meredith AL. KCNMA1-linked channelopathy. J Gen Physiol. 2019;151:1173–89.
CAS PubMed PubMed Central Google Scholar
Tabarki B, AlMajhad N, AlHashem A, Shaheen R, Alkuraya FS. Homozygous KCNMA1 mutation as a cause of cerebellar atrophy, developmental delay and seizures. Hum Genet. 2016;135:1295–8.
Lammertse HCA, van Berkel AA, Iacomino M, et al. Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission. Brain. 2020;143:441–51.
Molinari F, Raas-Rothschild A, Rio M, et al. Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet. 2005;76:334–9.
Poduri A, Chopra SS, Neilan EG, et al. Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia. 2012;53:e146–50.
Mills PB, Surtees RAH, Champion MP, et al. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5’-phosphate oxidase. Hum Mol Genet. 2005;14:1077–86.
Papuc SM, Abela L, Steindl K, et al. The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study. Eur J Hum Genet. 2019;27:408–21.
Kumar R, Gardner A, Homan CC, et al. Severe neurocognitive and growth disorders due to variation in THOC2, an essential component of nuclear mRNA export machinery. Hum Mutat. 2018;39:1126–38.
CAS PubMed PubMed Central Google Scholar
Niturad CE, Lev D, Kalscheuer VM, et al. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features. Brain J Neurol. 2017;140:2879–94.
Nakayama T, Ishii A, Yoshida T, et al. Somatic mosaic deletions involving SCN1A cause Dravet syndrome. Am J Med Genet A. 2018;176:657–62.
Shirley MD, Tang H, Gallione CJ, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013;368:1971–9.
CAS PubMed PubMed Central Google Scholar
D’Gama AM, Walsh CA. Somatic mosaicism and neurodevelopmental disease. Nat Neurosci. 2018;21:1504–14.
Winawer MR, Griffin NG, Samanamud J, et al. Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol. 2018;83:1133–46.
CAS PubMed PubMed Central Google Scholar
Saitsu H, Kato M, Osaka H, et al. CASK aberrations in male patients with Ohtahara syndrome and cerebellar hypoplasia. Epilepsia. 2012;53:1441–9.
Srivastava P, Chaudhry C, Kaur A, Phadke SR, Panigrahi I. How experts make a call: copy number variation analysis in unusual/rare case scenarios. Neurol India. 2022;70:148–54.
Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020;22:245–57.
Jiang H, Tang M, Xu Z, et al. CRISPR/Cas9
留言 (0)